Alternate Thursdays, noon - 1 p.m.
This 16-session ECHO series will cover the screening, diagnosis, and treatment of:
We will select clinical teams to participate based on interest, geographic distribution throughout Oregon, and ability to commit to the sessions. Clinical teams will include at least one prescribing clinician (MD, DO, PA, NP) and up to two other supporting staff that are in a position to develop new systems and processes to support care delivery. Other supporting staff could include a practice manager, quality improvement manager, behavioral health clinician, nurse care manager, pharmacist, or medical assistant.
*Accreditation: Oregon Health & Science University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit: OHSU School of Medicine designates this live activity for a maximum of 16.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
|1 - Introductions; Language around SUD; Basic Epidemiology of HCV and Testing Review; Transmission; Review Case Form||9/15/2022|
|2 - Population Health: Systems & The Role of Information Technology and Developing a Care Cascade Report; Lab Bundle and Care Cascade Disparities||9/29/2022|
|3 - Basic of Treatment with DAA’s (HCV Guidelines); Treatment Interruption||10/6/2022|
|4 - Treatment Program Overview; Telemedicine Model; Building Your Team in Primary Care; Developing Leadership Buy In; Developing Community Partner Networks||10/20/2022|
|5 - Patient Panel||11/3/2022|
|6 - Assessing Fibrosis of the Liver||11/17/2022|
|7 - Pharmacy Driven Tx; HAV, HBV Vaccines||12/1/2022|
|8 - Natural History of Cirrhosis and its Complications; Prognosis, Monitoring of ESLD, Mangement of Decompensated Cirrhosis||12/15/2022|
|9 - HCV Treatment in Special Populations; HCV and Reproductive Health; HCV in Decompensated Cirrhosis, Acute Hep C||1/12/2023|
|10 - SUD diagnosis, MOUD & MAUD||1/26/2023|
|11 - Hepatitis B infection||2/9/2023|
|12 - Harm Reduction||2/23/2023|
|13 - Integrating Peers and Community Outreach||3/9/2023|
|14 - Hepatocellular Carcinoma||3/30/2023|
|15 - When to Refer for Liver Transplant||4/13/2023|
|16 - ECHO Wrap-up, Case Updates||4/27/2023|